World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
33556
World Ranking
11245
National Ranking
5773

Ian Ganly publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ian Ganly sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 442 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ian Ganly D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ian Ganly sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ian Ganly is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research contributions predominantly lie within the field of Medicine, with significant focus on Surgery and Oncology. Additional subfields of interest include Otorhinolaryngology, Endocrinology, Diabetes and Metabolism, as well as Pulmonary and Respiratory Medicine.

Their scholarly work encompasses a range of topics emphasizing cancers of the head and neck region. Primary research themes involve:

  • Head and Neck Cancer Studies
  • Thyroid Cancer Diagnosis and Treatment
  • Head and Neck Surgical Oncology
  • Salivary Gland Tumors Diagnosis and Treatment
  • Thyroid and Parathyroid Surgery
  • Ear and Head Tumors
  • Bone Tumor Diagnosis and Treatments

Ian Ganly has frequently collaborated with the following researchers:

  • Richard J. Wong
  • Snehal G. Patel
  • Marc A. Cohen
  • Jatin P. Shah
  • Luc G.T. Morris

The venues where Ian Ganly's research is most often published include:

  • Cancer
  • International Journal of Radiation Oncology*Biology*Physics
  • Head & Neck
  • Journal of Clinical Oncology
  • Oral Oncology

Recent publications associated with or relevant to Ian Ganly's research include:

  • "Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors," 2021, Nature Communications
  • "The association between tumor mutational burden and prognosis is dependent on treatment context," 2021, Nature Genetics
  • "Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study," 2020, Journal of Clinical Oncology
  • "Delaying surgery for patients with a previous SARS-CoV-2 infection," 2020, British Journal of Surgery
  • "The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype," 2020, Clinical Cancer Research

Best Publications

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

    Fadlo R. Khuri;John Nemunaitis;Ian Ganly;James Arseneau

  • Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

    Iñigo Landa;Tihana Ibrahimpasic;Laura Boucai;Rileen Sinha

  • The head and neck cancer immune landscape and its immunotherapeutic implications.

    Rajarsi Mandal;Yasin Şenbabaoğlu;Alexis Desrichard;Jonathan J. Havel

  • Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer

    J. Nemunaitis;F. Khuri;I. Ganly;J. Arseneau

  • A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer

    Ian Ganly;Ian Ganly;David Kirn;Susan G. Eckhardt;Gail I. Rodriguez

  • Selective Replication and Oncolysis in p53 Mutant Tumors with ONYX-015, an E1B-55kD Gene-deleted Adenovirus, in Patients with Advanced Head and Neck Cancer: A Phase II Trial

    John Nemunaitis;Ian Ganly;Fadlo Khuri;James Arseneau

  • The Mutational Landscape of Adenoid Cystic Carcinoma

    Allen S Ho;Kasthuri Kannan;David M Roy;Luc G T Morris

  • Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease

    Iñigo Landa;Ian Ganly;Timothy A. Chan;Norisato Mitsutake

  • Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance

    R. Michael Tuttle;James A. Fagin;Gerald Minkowitz;Richard J. Wong

  • Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation

    Luc G T Morris;Andrew M Kaufman;Yongxing Gong;Deepa Ramaswami

  • Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer

    Luc G.T. Morris;Andrew G. Sikora;Snehal G. Patel;Richard B. Hayes

  • Postoperative complications of salvage total laryngectomy.

    Ian Ganly M.D.;Snehal Patel;Jeanette Matsuo;Bhuvanesh Singh

  • Complications of craniofacial resection for malignant tumors of the skull base: Report of an International Collaborative Study

    Ian Ganly;Snehal G. Patel;Bhuvanesh Singh;Dennis H. Kraus

  • Survival outcomes after treatment of cancer of the oral cavity (1985-2015)

    Daniella Karassawa Zanoni;Pablo H. Montero;Jocelyn C. Migliacci;Jatin P. Shah

  • Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy

    N. Gopalakrishna Iyer;Luc G. T. Morris;R. Michael Tuttle;Ashok R. Shaha

  • Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy.

    Iain J. Nixon;Ian Ganly;Snehal G. Patel;Frank L. Palmer

  • Early stage squamous cell cancer of the oral tongue—clinicopathologic features affecting outcome

    Ian Ganly;Snehal Patel;Jatin Shah

  • Immunogenic neoantigens derived from gene fusions stimulate T cell responses.

    Wei Yang;Ken Wing Lee;Raghvendra M. Srivastava;Fengshen Kuo

  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors.

    Cristina Valero;Mark Lee;Douglas Hoen;Kate Weiss

Frequent Co-Authors

Snehal G. Patel
Snehal G. Patel Memorial Sloan Kettering Cancer Center
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center
Ashok R. Shaha
Ashok R. Shaha Memorial Sloan Kettering Cancer Center
Richard J. Wong
Richard J. Wong Memorial Sloan Kettering Cancer Center
Nancy Y. Lee
Nancy Y. Lee Memorial Sloan Kettering Cancer Center
Luc G. T. Morris
Luc G. T. Morris Memorial Sloan Kettering Cancer Center
Ronald Ghossein
Ronald Ghossein Memorial Sloan Kettering Cancer Center
R. Michael Tuttle
R. Michael Tuttle Memorial Sloan Kettering Cancer Center
Marc Cohen
Marc Cohen RWJBarnabas Health
Bhuvanesh Singh
Bhuvanesh Singh Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, there are a variety of related online degrees that provide faster and more flexible ways to enter the healthcare field. Many aspiring healthcare professionals seek advanced roles through nursing programs that offer accelerated pathways.

For those considering a terminal degree in nursing, exploring the shortest online dnp program options can help you complete your education quickly. Additionally, comparing the shortest dnp program choices can make your journey to a Doctor of Nursing Practice more accessible.

If you’re looking for a quicker entry-point to nursing, an accelerated lpn program provides a fast-track to becoming a Licensed Practical Nurse. For those aiming to specialize in mental health, pursuing the shortest pmhnp program can lead to a rewarding role as a Psychiatric-Mental Health Nurse Practitioner. These pathways offer efficient, high-quality alternatives for building a medical career beyond the traditional MD path.

Best Scientists Citing Ian Ganly

Trending Scientists

Recently Published Articles